Although it can be determined that glycolysis does contribute to NLRP3 inflammasome activation, the idea of regulating inflammasomes by glycolysis has been experimentally demonstrated in the treatment of many inflammatory diseases, such as atherosclerosis, obesity, diabetes, tuberculosis and Rheumatoid arthritis. This evidence concerns the gene NLRP3 and diabetes mellitus.